Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Guotai Junan Haojing Investment Management is a specialized investment firm based in Shanghai, China. It operates as a subsidiary of Guotai Junan Innovation Investment, which is the private equity arm of the major financial group Guotai Junan Securities. The company focuses on managing funds that invest in high-growth sectors, with a particular emphasis on the healthcare, biotechnology, and life sciences industries. Its portfolio typically includes innovative companies involved in drug discovery, medical devices, and healthcare services. By providing strategic capital and leveraging its parent company's extensive financial network, the firm supports the growth of the Chinese healthcare ecosystem. Guotai Junan Haojing plays a vital role in bridging the gap between capital markets and scientific innovation in the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Guotai Junan Haojing Investment Management.